Search

Phylogica sinks on licensing setback

Shares in Subiaco-based biotech firm Phylogica have plummeted on the ASX after a potential licensing deal with a subsidiary of pharmaceutical giant Johnson & Johnson effectively collapsed.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Phylogica (PYC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BNiQ Disclaimer